Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2003
11/26/2003EP0673937B1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
11/26/2003CN1458921A Process for making N-aryl-anthranilic acid and their derivatives
11/26/2003CN1128798C Pharmaceutically active tricyclic amines
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/25/2003US6653481 Used as calcium channel blockers
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653153 Encoding metal salts are impregnated onto the support unit, with isotope distribution of the metal in the salt used as code; insoluble metal salts are formed to improve metal's retention
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003US6652601 Agent for dyeing fibers comprising an indoline/indolium derivative
11/25/2003CA2061168C The preparation and use of 3, (4)-substituted pyrrolidines as catalysts for the polyisocyanate polyaddition process
11/20/2003WO2003094914A1 Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
11/20/2003WO2003013512A3 Crystalline forms of fluvastatin sodium
11/20/2003US20030216583 Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols
11/20/2003US20030216572 Process to produce oxazolidinones
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216494 Free radical catalyst for addition polymer
11/20/2003US20030216462 Anticancer agents; psoriasis
11/20/2003US20030216452 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216405 Hydroxycarbonyl or alkyloxycarbonyl or aminohydroxycarbonyl substituted sulfonamide compounds useful as procollagen C-protenase inhibitor
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216356 Cause the selective destruction of tumour vasculature; are used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis
11/20/2003US20030216260 Preparation by intramolecular cyclization
11/20/2003US20030216258 Condensed heterocylic compounds and herbicides containing them as active ingredients
11/20/2003US20030215667 Electroluminescent devices
11/20/2003US20030215523 Medicinal compositions for concomitant use as anticancer agent
11/20/2003US20030213071 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair)
11/20/2003CA2483991A1 Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
11/19/2003EP1362864A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
11/19/2003EP1362601A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/19/2003EP0831811B1 Carbazoles for treating microbial infections
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/19/2003CN1128138C Carbazole alkaloid derivative and its prepn and use
11/19/2003CN1128137C Indole compounds and its synthetic method
11/18/2003US6649772 3,6,9-Trisubstituted carbazoles for light emitting diodes
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649639 Inhibit or block the biological activity of the picornaviral 3C protease.
11/18/2003US6649634 Use in treating diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/13/2003WO2003093302A2 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
11/13/2003WO2003093281A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
11/13/2003WO2003093220A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids
11/13/2003WO2003092679A1 Preparation of phosphatase inhibitors
11/13/2003WO2003092643A1 Light-protection formulations using acrylonitrile derivatives
11/13/2003WO2003092626A2 Carvedilol pharmasolve solvate
11/13/2003WO2003092622A2 Carvedilol monocitrate monohydrate
11/13/2003WO2003029213A9 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/13/2003WO2002057231A8 Benz(g) indoles and their use as spla2 inhibitors
11/13/2003WO2002050030A8 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
11/13/2003WO2002050029A8 Tetracyclic derivatives as spla2 inhibitors
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003US20030212278 Using dihydropyran, triethyl orthoformate and alkyl acrylate
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212113 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003CA2484624A1 Carvedilol pharmasolve solvate
11/13/2003CA2483830A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids
11/13/2003CA2483566A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
11/13/2003CA2483054A1 Carvedilol monocitrate monohydrate
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1359940A2 Combinations of statins, estrogenic agents and optionally estrogens
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003CN1455770A (2-azabicyclo [2,2,1] hept-7-yl] methanol derivatives as nicotinic acetylcholine receptor agonisis
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
11/12/2003CN1127483C Tert-butyl (3R,5R)-3, 5-dihydroxy-7-N-phthaloylimino heptanonate and its synthesis and use thereof
11/12/2003CN1127482C Sulfuryl diphenyl indole compound and preparation process and use in medicine
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645968 Potassium channel openers
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/06/2003WO2003091689A2 Bis-transition-metal-chelate-probes
11/06/2003WO2003091396A2 Polypeptides and biosynthetic pathways
11/06/2003WO2003091262A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom
11/06/2003WO2003091215A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo’ b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
11/06/2003WO2003091213A1 Novel amide derivatives or salts thereof
11/06/2003WO2003091211A1 Novel heteroaryl compounds
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003057670A3 Indoles as naaladase inhibitors
11/06/2003WO2003032901A3 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002059117A8 Piperazine- and piperidine-derivatives as melanocortin receptor agonists